Families often ask us this in the first phone call, so we wrote it down properly.
All guidesA guide for patients and families
How RFQMR Works
Rotational Field Quantum Magnetic Resonance is an energy-based technology that works with the natural electrical signalling inside your cells. This guide explains what it is, the thinking behind it, and what researchers have and have not established so far — in everyday language.
Every cell in your body runs on a tiny battery
Your cells are not just chemistry. Each one holds a small electrical charge across its outer skin — a difference between the inside and the outside of the cell.
Scientists call this the trans-membrane potential, or TMP. It is measured in millivolts, and it is one of the ways a cell knows what to do and when to do it. The cell uses this electrical signal to decide when to make particular proteins, when to divide, when to repair itself, and when to stop.
When that signalling is disturbed, the protein-making process can go wrong. Research has linked disturbances in this process to a range of conditions — cancer among them, but also heart disease, degenerative problems such as cartilage loss, and various forms of inflammation.
That observation led to a question, put forward by Dr. R. V. Kumar: if the cell's charge could be altered deliberately and in a controlled way, could the processes that depend on it be influenced too? RFQMR is the technology built to test that idea.
A cell is a little like a rechargeable device. When the battery reads normally, everything runs as designed. When the reading drifts away from normal, the device starts behaving in ways it shouldn't — not because a part is missing, but because the power level itself has changed.
The charge sits across the cell membrane — more positive outside, more negative inside. A healthy cell typically reads between −70 and −90 millivolts.
What that battery reads in different cells
The reading is not the same everywhere. It changes in a fairly consistent way depending on the state the cell is in — and that difference is what makes a targeted approach conceivable in the first place.
Normal cells hold the strongest charge. Infected cells sit weaker. Cancer cells are weaker again, at roughly −20 to −30 mV. At zero, the cell is no longer alive.
Read that scale from right to left and you are watching a cell lose its grip. A normal, working cell holds a strong charge. A cell under infection holds less. A cancer cell holds less still. At zero, there is nothing left.
This matters for one practical reason: a cancer cell and the healthy cell sitting next to it are not electrically identical. They differ, measurably. Any technology hoping to affect one and not the other has to start from a difference like this.
Two radios in the same room can be tuned to different stations. A broadcast sent on one frequency reaches one of them and passes the other by — not because it was aimed more carefully, but because the two are set to receive different things.
Three ways energy can act on the body
This is the question patients ask first: is this radiation? The clearest answer comes from understanding that energy can affect living tissue in three quite different ways.
RFQMR belongs to the third category. It is described as working by transmitting a patterned signal to cells, not by depositing destructive energy into them.
Ionising energy — the kind used in X-rays and radiotherapy — has enough force to knock electrons out of atoms. It is effective, but it does not distinguish carefully between what it passes through.
Thermal energy — as in radiofrequency ablation — works by heat. Push the temperature high enough at the target and the tissue there is destroyed.
Non-ionising and non-thermal is the category RFQMR falls into. It neither strips electrons nor cooks tissue. The proposal is that its effect comes from the pattern of the signal — the waveform, the sequence of waves, the timing of the modulation, the rotation and spin around the target — rather than from raw energy. On this account, a radiofrequency beam is useful here for the same reason it is useful in broadcasting: it can be modulated very precisely, and so it can carry detailed instructions.
There are three ways to get through a locked door. You can break it down. You can burn it. Or you can send the lock the correct code and let it open itself. The first two rely on force and damage whatever is nearby. The third relies on the door being able to recognise a specific signal.
This is also why the research notes that specific variations in how RFQMR is configured and timed can produce quite specific biological responses — in the same way that different drugs, chemically similar on the surface, do very different things in the body.
Tuned, not blasted
RFQMR delivers radiofrequency energy across a wide span of frequencies, inside a strong magnetic field, through a specialised antenna held close to the treatment area.
The frequency range used runs from 3 Hz — slower than a heartbeat — up to 300 MHz, along with its harmonics. This happens in the presence of a high instantaneous magnetic field, and the delivery is "near field", meaning the antenna works at close range rather than broadcasting into the room.
What matters for you as a patient is the consequence of that design: the delivery is described as highly cell-specific and site-specific. The settings take into account the proton density of the tissue, its permittivity, the depth the beam needs to reach, and the particular resonance of the elements present.
An opera singer can shatter a wine glass by holding exactly the note the glass resonates at. Every other glass on the table, and every other object in the room, is untouched. Nothing was aimed at the glass — it simply happened to be the only thing that responded to that particular note.
That is the working principle. The intent is not to deliver more energy, but to deliver a more precisely matched signal.
The same field is present around both cells. Only the one matched to the signal responds.
Why one cell responds and its neighbour doesn't
Cancer cells are not simply healthy cells behaving badly. Physically, they are built differently — and those physical differences are what the technology relies on.
Diseased tissue differs from healthy tissue in measurable physical properties: its proton density (how many hydrogen atoms it contains), its permittivity (how it responds to an electric field), and its conductivity (how readily it carries a current). These are not small technicalities. They are the reason a signal can affect one population of cells while passing through another.
Both cells sit in the same field. Their physical make-up — not their location — determines how each one responds.
Put a bowl of soup and a ceramic plate in a microwave together. Same oven, same setting, same time. The soup is steaming and the plate is barely warm — because water and ceramic simply respond differently to that energy. Nothing targeted the soup; the difference was already in the materials.
Working from this, researchers have focused on cell functions that could be influenced this way: the ion pumps in the membrane, the enzyme reactions in the cell fluid, and the processes involved in cell replication. The observation from this line of work is that these effects can be produced without ionising and without heating.
Inside the cell's power plant
This is the heart of how RFQMR is proposed to work in cancer. It is worth taking slowly, because the idea is elegant once the picture is clear.
Inside every cell sit the mitochondria — the structures that produce ATP, the cell's energy currency. Dividing is expensive. A cell that wants to multiply needs a great deal of ATP to do it.
On the membrane of the mitochondrion sit sensors — glycoproteins — that regulate how much of the "make energy now" signal gets through. Think of them as a dimmer switch. In a cancer cell, the proposal is that these sensors have been altered so that their electrical resistance has dropped. With the resistance low, the sensors stop discriminating between signals, and the instruction to produce ATP effectively never switches off. The cell is flooded with energy, and it divides, and divides again.
The proposed mechanism: RFQMR lengthens a molecular chain on the sensor, raising its resistance, so the constant "produce energy" signal no longer gets through.
RFQMR is proposed to act on exactly this point. The spin of the field is used to interfere with the communication between the cell's genes and these sensors — the conversation that drives division. In the process, a molecular chain on the sensor is lengthened, which raises its resistance and closes the gate that had been stuck open.
Imagine a factory where the thermostat has failed and the furnace runs at full output around the clock. Nobody ordered it; the control that should regulate it has stopped working. RFQMR is proposed to work not by shutting the furnace down by force, but by restoring resistance to that control — so the runaway instruction stops getting through.
Importantly, normal cells are not expected to be affected in the same way. Their mitochondrial sensors are not altered, so they continue to receive the ordinary signals from the chromosomes and carry on producing energy as usual.
The backup switch
Healthy cells have a built-in safety mechanism: when something goes seriously wrong, a protein called p53 triggers an orderly shutdown before the damage can spread.
In many cancers, p53 is already mutated. The switch is broken — which is part of why the cancer was able to establish itself in the first place. Pressing harder on a broken switch does not help.
There is, however, a second protein that does similar work: p73, described in the research as p53's silent partner. Because p53 is likely to be damaged from the outset, p73 is the pathway RFQMR is aimed at.
A building's main fire alarm has been disconnected. Rather than trying to repair it in the middle of an emergency, you reach for the secondary alarm on the other stairwell — one that was always there, wired to the same system, and still working.
With p53 likely already damaged, the proposed approach works through p73 instead.
Two ways a targeted cell can end
Not all tumour cells behave the same way, and the research describes two distinct responses depending on how developed the cells are.
The distinction is between undifferentiated cells — the more primitive, aggressive kind that have lost most of their original identity — and differentiated cells, which still resemble the tissue they came from.
The proposed outcomes differ by cell type. Normal cells are not expected to be influenced in the same way.
Undifferentiated cells are described as having the greatest change induced in their sensors — the highest resistance. On this account they stop producing ATP altogether and, in the words of the research, this "possibly" leads to necrosis: the cell simply fails.
Differentiated cells retain some sensitivity to the ordinary signals. Rather than failing outright, they are described as changing state and becoming quiescent — going quiet, no longer dividing — until they eventually undergo apoptosis, the body's own orderly process for retiring a cell.
Necrosis is a machine seizing up mid-operation. Apoptosis is the same machine being powered down properly at the end of a shift, cleaned and put away. Both end in the machine stopping; the second is far tidier for everything around it.
In tumours of the chest that have been exposed to RFQMR, there is evidence that some underwent necrosis and others apoptosis. In some cases both were seen together — with apoptosis the more pronounced of the two.
Where this started: the knee
The first application of RFQMR studied scientifically had nothing to do with cancer. It was cartilage.
Cartilage loss in the knee is a problem of cells that have stopped renewing themselves. The chondrocytes — the cells that maintain cartilage — become terminally differentiated: settled into their final form and no longer dividing.
In that work, the RFQMR beam was precisely focused onto the joint. This generated what are called streaming voltage potentials: movement of hydrogen protons in the tissue around the cells, caused by a change in the spin of those hydrogen atoms and the resonance that follows.
The result was a drop in the trans-membrane potential of those settled chondrocytes — which in turn stimulated production of the proteins needed to begin dividing again, allowing the tissue to regenerate.
The same protein-stimulating principle appears in the cancer context, aimed at a different target: the HSP 70/90 group of proteins for cartilage regeneration, and the p53 and p73 pathway in neoplastic disorders.
The first studied use of RFQMR: restarting cell division in knee cartilage.
What is established, and what is still theory
You deserve a clear line between the two. The research literature on RFQMR draws it carefully, and so should we.
What is established
That trans-membrane potential is a real cellular signalling pathway, and that it differs measurably between normal, infected and cancerous cells. That electromagnetic fields can modulate biological functions in a controlled way — a field of study with a century of research behind it. That RFQMR is non-ionising and non-thermal, which places it in a different category from radiotherapy and from ablation. And that the cartilage application was studied first and provided the foundation for everything that followed.
What comes from laboratory work
Preliminary observations performed in vitro — in cell cultures, not in patients — have shown changes in cell shape, in how cells multiply, in cell fusion, and in necrosis, across lymphoblastoid cell lines and some cancer cell lines exposed to specifically modulated radiofrequency radiation.
What remains a working hypothesis
The detailed mechanism described in chapters 6 to 8 — the mitochondrial sensors, the resistance change, the p73 pathway, the split between necrosis and apoptosis — is presented in the source research as a hypothesis. The language used is deliberate: "it is hypothesised", "it is supposed that", "it is thought that", and the outcome in undifferentiated cells is described as one that "possibly" induces necrosis. It is a coherent and carefully reasoned proposal. It is not the same as a settled fact, and we will not present it to you as one.
Questions worth asking your care team
- Where does this fit alongside my existing treatment? RFQMR is not proposed as a replacement for your oncology care.
- What is known about my specific tumour type? The research describes different responses in differentiated and undifferentiated cells.
- What should I expect to feel? The technology is non-thermal and non-ionising, so ask what the session itself involves.
- What would we be watching for, and over what period? Ask how response would be assessed in your case.
Please note. This page explains the scientific reasoning behind a technology. It is educational material, not medical advice, and it does not promise any particular outcome. Every patient's situation is different. Decisions about your treatment should always be made together with your treating doctors, who know your full history.